Loading...
How we treat cytomegalovirus in hematopoietic cell transplant recipients
Cytomegalovirus (CMV) continues to cause major complications after hematopoietic cell transplantation (HCT). Over the past decade, most centers have adopted preemptive antiviral treatment or prophylaxis strategies to prevent CMV disease. Both strategies are effective but also have shortcomings with...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2700312/ https://ncbi.nlm.nih.gov/pubmed/19299333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-10-143560 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|